Vikram D. Durairaj
Department Of Otolaryngology Head And Neck Surgery,
Denver, Colorado
United States
Research Article
Endoscopic Management of Acquired Nasolacrimal Duct Obstruction Secondary to Radioactive Iodine Treatment for Thyroid Malignancy
Author(s): Vijay R. Ramakrishnan, Vikram D. Durairaj and Todd T. Kingdom*Vijay R. Ramakrishnan, Vikram D. Durairaj and Todd T. Kingdom*
Introduction: Radioactive iodine (RAI) has been used in the management of thyroid malignancy for over 60 years. Established side effects of xerophthalmia, xerostomia, and sialadenitis are well known, and may occur in a dose-dependent manner. Acquired nasolacrimal duct obstruction (NLDO) has recently been described, with an estimated occurrence in 4% of patients receiving substantial doses of RAI for malignancy. To date, there are no published efforts of endoscopic management of this disease process.
Objectives: Given that thyroid malignancy and the use of RAI appear to be increasing in annual incidence, we aim to raise awareness of this common therapeutic side effect and to describe our success with endoscopic management of this condition.
Methods: Retrospective review of 5 patients (10 sides) treated for acquired NL.. View More»
DOI:
10.4172/2155-6121.1000110